It's the end of an era - as WeightWatchers files for bankruptcy after 62 years in business. The company's New Zealand arm closed in-person workshops last year, and it's seen struggles across the ...

Many people want to be doctors, but not everyone has the financial capabilities to study medicine. On average, pursuing a medical programme takes about six years, which is at least two to three years ...

This article discusses several natural remedies for gout, other treatment options, and how to manage a flare-up. According to the Arthritis Foundation, drinking enough water encourages the kidneys ...

Sometimes, people refer to these products as “smart drugs” or “nootropics.” Manufacturers market nootropics with the idea that they may affect the brain by influencing neurons and ...

“Overconsumption of supplements could lead to a rapid clearance of the prescription medicine from the body, and that could result in making the medicine less effective.” The primary compound ...

At the School of Veterinary Medicine, we aim to inspire and educate veterinary professionals who will advance veterinary medicine to meet the needs of a changing world. We’re home to world-class ...

"It was devastating," she told Newsweek. Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 ...

Of the 804 patients who underwent randomization, 403 were assigned to receive mepolizumab and 401 to receive placebo. The annualized rate of moderate or severe exacerbations was significantly ...

April 29, 2025 – Prostate cancer is the second-deadliest cancer among U.S. men – and it's on the rise. More than 300,000 men are diagnosed with the condition each year, a number that's been ...

A report into HMP Foston Hall in Derbyshire and young offender institution (YOI) said the easy access to drugs and "very high levels of mental health need" were contributing to violence.

The first “biological missile" drug that was approved to treat breast cancer just got a step closer to being approved as a first-line treatment for patients with HER2-positive metastatic breast cancer ...